Literature DB >> 11793301

[Not Available].

J Weis1, R Schwarz, G Blettner.   

Abstract

Epidemiological data show that 40-50% of all cancer patients develop some kind of psychosocial disturbancy during the course of their illness and about 30% will require professional support. Even if there exists a considerable body of knowledge and a differentiated health care System, the vast majority of cancer patients have no chance to receive any proper psychosocial care due to the lack of facilities like psychosocial outpatient Services in the communities and specifically trained psychooncologists on oncology wards, whereas the number of psychooncologists in rehabilitation-clinics seems to be sufficient. Psychooncological societies have established training courses and formulated guidelines relating to some important aspects of psychosocial research and practice, in order to promote good quality in the psychosocial care of cancer patients.

Entities:  

Keywords:  Cancer rehabilitation; Psychosocial co-morbidity; Quality of care

Year:  2000        PMID: 11793301     DOI: 10.13109/zptm.2000.46.1.4

Source DB:  PubMed          Journal:  Z Psychosom Med Psychother        ISSN: 1438-3608            Impact factor:   0.791


  4 in total

1.  [Need for psychosocial care in in-patients with tumour disease. Investigations conducted in a clinic specializing in tumour surgery].

Authors:  U Goerling; S Odebrecht; G Schiller; P M Schlag
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

2.  Use of psychosocial services by lung cancer survivors in Germany : Results of a German multicenter study (LARIS).

Authors:  Martin Eichler; Marlene Hechtner; Beatrice Wehler; Roland Buhl; Jan Stratmann; Martin Sebastian; Heinz Schmidberger; Cornelius Kortsik; Ursula Nestle; Hubert Wirtz; Thomas Wehler; Maria Blettner; Susanne Singer
Journal:  Strahlenther Onkol       Date:  2019-07-10       Impact factor: 3.621

3.  Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study.

Authors:  Susanne Singer; Wolfgang Janni; Thorsten Kühn; Felix Flock; Ricardo Felberbaum; Lukas Schwentner; Elena Leinert; Achim Wöckel; Tanja Schlaiß
Journal:  Arch Gynecol Obstet       Date:  2022-07-15       Impact factor: 2.493

4.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.